The head of the Federal Trade Commission (FTC) and Makan Delrahim met with Chinese officials in Beijing last week to discuss efforts to ensure effective antitrust enforcement and increased interagency cooperation.
The meetings covered a wide range of topics including enforcement and policy developments and priorities, the antitrust treatment of conduct involving intellectual property and its role in promoting innovation, and future opportunities for cooperation. The agencies also exchanged views on the role of sound and effective procedures in competition enforcement and the importance of competition advocacy. Meetings will continue through Friday with separate meetings between US antitrust enforcers and each of the three Chinese agencies.
In attendance at the meeting from the US government were Maureen Ohlhausen, acting chair of the FTC, and Makan Delrahim, assistant attorney general of the Justice Department’s Antitrust Division. They met with Hu Zucai, vice chair of China’s National Development and Reform Commission (NDRC); Zhang Handong, director general from the Ministry of Commerce (MOFCOM); and NDRC Chairman He Lifeng, along with several others.
Full Content: Financial Regulation News
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas